News

Mosaic Neo mitral valve from Medtronic

The Mosaic Neo mitral bioprosthesis can be implanted through sternotomy, minimally invasive cardiac surgery or robotic access. 

Heart Rhythm 2026 Program Chair Dhanunjaya "DJ" Lakkireddy, MD, MBA, FHRS, Executive Medical Director, Kansas City Heart Rhythm Institute, and professor of medicine at the University of Kansas Health System, offers an overview of key trends in electrophysiology (EP) technology.

Heart Rhythm 2026 Program Chair DJ Lakkireddy, MD, spoke to Cardiovascular Business during the conference about several key EP trends. 

doctorwithpatient.jpg

The idea is spreading thanks to a new startup focused on providing support for cardiologists.

healthcare surprise billing statement payment

Over 100 specialty societies and state medical associations wrote to Health and Human Services and other departments to voice their growing frustration with the No Surprises Act. 

IR Centers

Founded by interventional radiologist Sandeep Bagla, MD, IR Centers is a platform helping other specialties manage and deliver such services. 

M&A mergers and acquisitions business deal

The Nashville, Tennessee, company—which offers AI to monitor radiology reports for unexpected findings—has reached a deal to buy Thynk Health for an undisclosed sum. 

hospital at home HaH

Earlier this year Congress extended CMS’s hospital-at-home waiver for five years via the Consolidated Appropriations Act of 2026. With that bold stroke, ‘HaH’ services became eligible for Medicare reimbursement through September of 2030. 

Thumbnail

Washington Physicians Health Program (WPHP), a contractor with the state health department, is accused of trapping two physicians into mental health treatment as a condition of maintaining their medical residency jobs. Plaintiffs in the lawsuit are seeking class action status. 

GLP-1 receptor agonists (GLP-1-RAs) have become the wonder drug not only of weight loss, but also for improving cardiovascular health in a growing number of positive cardiovascular trials. The latest study of more than 13,000 patients presented at Heart Rhythm 2026 this week showed the GLP-1 reduce atrial fibrillation (AFib) and survival, even after accounting for the drug’s impact on weight loss.

The popular drugs, originally developed to treat diabetes, were also associated with an improved survival rate. Benefits were seen in patients who did and did not lose significant weight as a result of treatment. 

Medicare Advantage

Several healthcare stakeholders have voiced their support for the effort, including the Medical Group Management Association. 

Thumbnail

However, radiology dropped to 18th on the list of specialists when asked how they feel about their profession’s long-term future, according to new survey data from Medscape. 

survey polling quick data check mark poll research doctor

Published in Clinical Imaging, the responses indicate that Trump administration policies have made it more difficult to acquire funding and collaborate with other researchers. 

Around the web

The Mosaic Neo mitral bioprosthesis can be implanted through sternotomy, minimally invasive cardiac surgery or robotic access. 

Heart Rhythm 2026 Program Chair DJ Lakkireddy, MD, spoke to Cardiovascular Business during the conference about several key EP trends. 

The idea is spreading thanks to a new startup focused on providing support for cardiologists.